Hyperphagia: Clinical Trials

9 trials for Hyperphagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Terminated 9
Phase 32Terminated 2
Phase 11Terminated 1

Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Naltrexone In Pediatric Eating Disorders
Naltrexone Hydrochloride, Control - Anorexia Nervosa/Bulimia, Anorexia in Adolescence
Phase 2 / Phase 3TerminatedRosemary Claire Roden92022-04-222025-08-19
Binge Eating & Birth Control
Drospirenone-Ethinyl Estradiol Oral Tablet - Bulimia Nervosa, Binge Eating
Phase 2TerminatedUniversity of North Carolina, Chapel Hill82020-09-242022-07-26
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Livoletide, Placebo - Prader-Willi Syndrome, Hyperphagia
Phase 2 / Phase 3TerminatedMillendo Therapeutics SAS1582019-03-252021-02-17
Lisdexamfetamine for Adults With Bulimia Nervosa
Lisdexamfetamine dimesylate - Bulimia Nervosa
Phase 2TerminatedAaron Keshen232018-06-212020-11-27
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
SMOFlipid - Cholestasis, Jaundice, Obstructive
Phase 1 / Phase 2TerminatedUniversity of Florida22016-05-012017-04-17
The Energy Dose Study
Parenteral Nutrition, Propofol, Clevidipine - Critical Illness
Phase 2TerminatedEmory University122011-07-012022-06-10
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
Omegaven - Cholestasis
Phase 2TerminatedUniversity of California, Los Angeles622009-08-012020-02-26
Effect of a CCK-1R Agonist on Food Intake in Humans
GSKI181771X (CCK-1R agonist), Instructions to binge eat, Instructions to eat normally - Bulimia
Phase 2TerminatedSt. Luke's-Roosevelt Hospital Center402008-01-012017-04-28
Total Parenteral Nutrition-Associated Liver Disease
Choline Chloride - Liver Diseases
Phase 2TerminatedNorthwestern University482001-09-012015-03-25

Narrower conditions

Bulimia (4)  ·  Bulimia Nervosa (3)  ·  Feeding and Eating Disorders (3)  ·  Cholestasis (2)  ·  Anorexia Nervosa (1)  ·  Binge-Eating Disorder (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Enterocolitis, Necrotizing (1)  ·  Impulsive Behavior (1)  ·  Jaundice, Obstructive (1)  ·  Liver Diseases (1)  ·  Malnutrition (1)  ·  Mental Disorders (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Signs and Symptoms, Digestive (9)  ·  Digestive System Diseases (3)  ·  Bile Duct Diseases (2)  ·  Biliary Tract Diseases (2)  ·  Mental Disorders (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathologic Processes (2)  ·  Abnormalities, Multiple (1)  ·  Behavior (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)

Interventions

Parenteral Nutrition (2)  ·  Choline (1)  ·  Enteral Nutrition (1)  ·  Lisdexamfetamine Dimesylate (1)  ·  Naltrexone (1)  ·  Propofol (1)  ·  SMOFlipid (1)  ·  clevidipine (1)  ·  cyclic des-acyl ghrelin (6-13) (1)  ·  drospirenone and ethinyl estradiol combination (1)  ·  fish oil triglycerides (1)

Sponsors

Aaron Keshen (1)  ·  Emory University (1)  ·  Millendo Therapeutics SAS (1)  ·  Northwestern University (1)  ·  Rosemary Claire Roden (1)  ·  St. Luke's-Roosevelt Hospital Center (1)  ·  University of California, Los Angeles (1)  ·  University of Florida (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (8)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Aaron Keshen, MD, FRCPC (1)  ·  Harry R. Kissileff, Ph.D. (1)  ·  Jeanine Albu, MD (1)  ·  Jessica Baker, PhD (1)  ·  Josef Neu, MD (1)  ·  Kara L Calkins, MD (1)  ·  Rosemary C Roden, MD (1)  ·  Thomas R Ziegler, MD (1)

Results publications

PMID 23894176, PMID 28521607, PMID 30411372, PMID 30900274, PMID 32072161, PMID 33534199, PMID 36167287, PMID 37218020

NIH funding

R21DK089369 (1)